Amedisys (NASDAQ: AMED) lost ground at the open Thursday, on word of an alliance with Baylor Scott & White Health, the largest not-for-profit health system in Texas, and Amedisys’ Contessa arm.
Contessa is the nation's leading high-acuity home care provider. The partnership is meant to provide patients with a high-quality continuum of care in the home.
The continuum of care will include new alternative care models to extend comprehensive, coordinated medical care to patients’ homes, including hospital-level care, palliative or supportive care, and skilled nursing care. Baylor Scott & White will begin communicating the new programs to eligible patients in 2023.
“We are dedicated to developing and delivering new, convenient options for our patients, offering high quality care when and where they want it,” said Baylor CEO Pete McCanna.
“These innovative at-home solutions will empower those we serve, enhancing the recovery process and improving outcomes.”
Once the programs are launched, eligible patients will be offered an alternative to conventional inpatient hospitalization as well as other services, including skilled nursing care at home and options for additional support and assistance for seriously ill patients, their families and caregivers.
Data shows that Contessa’s model reduces readmission rates by 44%, decreases the length of hospital stays by 35% and has a patient satisfaction rate of more than 90%.
As the largest not-for-profit health system in the state of Texas, Baylor Scott & White promotes the health and well-being of every individual, family and community it serves.
AMED shares stumbled $2.86, or 2.5%, to $112.75.
Related Stories
